JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2013, Vol. 51 ›› Issue (8): 74-77.

• Articles • Previous Articles     Next Articles

Expressions of centrosome α tubulin, P53 protein and telomerase in hepatocarcinoma and their correlations

LI Heng1, LI Zhe1, QIAO Xiao-jun1, GAO Ai-qin2, ZHANG Nan2   

  1. 1. Department of Preventive Medicine; 2. Department of Oncology,
    Jinan Central Hospital  Affiliated to Shandong University, Jinan 250013, China
  • Received:2013-05-08 Online:2013-08-10 Published:2013-08-10

Abstract:

Objective   To evaluate the expressions of centrosome α tubulin, P53 protein and telomerase in human hepatocellular carcinoma (HCC), paracancerous tissues, and cirrhosis / chronic hepatitis tissues, in order to investigate the correlations between centrosome abnormalities and telomerase in hepatocellular canceration. Methods   The paraffin-embedded tissues of 47 cases of HCC, 47 paracancerous tissues and 12 cirrhosis / chronic hepatitis tissues prepared in the Pathological Department of Jinan Central Hospital were selected. Immunohistochemistry SP method was applied to detect the expressions of centrosome α tubulin, P53 protein and human telomerase reverse transcriptase (hTERT). The correlations were then analyzed. Results   The expressions of α tubulin in HCC, paracancerous and cirrhosis /chronic hepatitis tissues were 59.57%, 23.4% and 16.67%; the expressions of P53 protein were 76.60%, 29.97% and 33.33%. The expressions were significantly higher in HCC than in paracancerous and cirrhosis /chronic hepatitis tissues (P<0.05). The positive expressions of hTERT were 68.09% in HCC, 34.04% in paracancerous tissues and 0% in cirrhosis /chronic hepatitis tissues, with significant difference (P<0.05). Expressions of α tubulin, P53 protein and telomerase were positively correlated. Conclusion    Centrosome abnormalities may participate in the development of HCC, and may serve as a new target for diagnosis and therapy.

Key words: Hepatocellular carcinoma; Centrosome; Telomerase; P53 protein

CLC Number: 

  • R735.7
[1] XU Wei, CHANG Hong, ZHAI Yun-peng. Construction of Livin shRNA eukaryotic expression vector and its influence on chemotherapeutic sensitivity of HepG2 cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(12): 20-24.
[2] MENG Hai-peng, NIU Wei-bo, WU Xiao-peng, GUO Sen, LIU Yi, CHEN Yu-xin. Effects of type of PVTT on long-term outcomes of  surgical treatment for hepatocellular carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(12): 61-66.
[3] CHEN Yuan-hong1, ZENG Yi1, LUO Yan-hong2. Effect of Rabdosia lophanthoides on the proliferation and apoptosis in hepatoma carcinoma cell line HepG2 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(11): 42-45.
[4] WANG Meng1, LIU Yan2, LI Jie2, SHI Dan-dan2, LIU Cong-cong2. Phantom investigation of the factors affecting the intensity of the twinkling artifact [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(8): 53-57.
[5] FAN Hai-yan, ZHANG Hui-jing, GUO Zhan-jun, LI Sheng-mian. Prognostic significance of RASSF1A and WIF-1 methylation in the cancer tissues of patients with HCC [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(5): 89-93.
[6] HU Liang, YI Yong-xiang, DING Hai, HAN Jian-bo, LIU Tao, ZHAO Liang. Relevant factors of postoperative complications for hepatectomy combined with splenectomy [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(1): 64-66.
[7] XU Xiao-mei1, YU Jiao1, LI Guo-hua1, JIANG Yan2, JIANG Zhao-quan3, ZHANG Ping3, CHENG Xiao-yun1. Clinical research on treatment of liver decompensation of primary
liver cancer by the method of Yiqibushenquyu
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(12): 70-.
[8] WANG Xiao-hua1, GAO Shu-chun1, CUI Lei2, JIANG Xue-mei1, DU Yi-zhen1. Serum interlukine-28B expression in HBV related primary
hepatocellular carcinoma patients and its significance
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(10): 106-110.
[9] WANG Xu, CHENG Bao-quan, LIANG Xu-yang, JIA Jun-ying, LI Qian-qian. Clinical significance of HMGB1 expression in
hepatocellular carcinoma cells
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(4): 38-41.
[10] WANG Kun-hong1, WANG Wen-qi2, XIANG Yu-fen1, WANG Yi-guo2, LIU Chang-hong2, LI Shuang-ling2, CAO Li-li3. Effect of down-regulating SnoN gene expression on proliferation
and apoptosis of HepG2 cells
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(4): 33-37.
[11] ZHAO Wen-bo1, LIU Xin1, LIU Xiao-qian2, CUI Xin1, WANG Xin1. Isolation of endothelial cells from hepatocellular carcinoma and
their PRL-3 expression
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(3): 108-112.
[12] WANG Xu-fu1,2, HAN Jian-kui1, LIU Xin-feng3, WANG Zhi-qiang1, SUN Jian-Wen1, ZUO Shu-yao2, YANG Guang-jie2. 125I seed implantation in rabbit VX2 liver tumor: evaluation of
therapeutic effects and damage to normal liver tissues
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(2): 30-33.
[13] YU De-xin, MA Xiang-xing, LI Du-min, ZHANG Xiao-ming, WANG Qian, LI Chuan-fu. Relationship between clinical-pathological features and metabolic status of  hepatocellular carcinoma detected by 31P magnetic resonance spectroscopy [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(11): 97-100.
[14] LI Yu-sheng, HUANG Li, L Qi-jun, YU Yong-qin. Effect of interferon α-2b combined with 5-fluorouracil on the biological behavior of hepatoma cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(9): 48-.
[15] XU Nuo, JIANG Junmei, FENG Shanshan, WANG Guanhua, MENG Mei, YIN Xiaoyan. Effect of endogenous NO on expression of HDAC4 in a  hepatocellular carcinoma model of nude mice [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(8): 48-51.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!